Sign inJoin waitlistJoin the waitlist

ES

Eric Sherman

Attending Physician · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
1996–1998
Bellevue Hospital
1993–1996
Columbia Univ Coll of Phys & Surgeons
1989–1993

Research

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
Journal of Clinical Oncology · 2014 · 671 citations
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
New England Journal of Medicine · 2013 · 633 citations
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
New England Journal of Medicine · 2020 · 631 citations

NL
Nancy Lee
104 papers
Nadeem Riaz
77 papers · 9 as a resident
David Pfister
65 papers
Richard Wong
59 papers
AH
Alan Ho
57 papers
Sean McBride
56 papers
LD
Lara Dunn
46 papers · 4 as a fellow
YY
Yao Yu
39 papers · 1 as a resident
Ian Ganly
35 papers
CT
Chiaojung Tsai
34 papers · 1 as a resident
DG
Daphna Gelblum
30 papers
NK
Nora Katabi
30 papers

Clinical trials

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2020–2027
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Principal investigator · Active not recruiting · Early phase 1
Memorial Sloan Kettering Cancer Center
2017–2026
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2013–2027
Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2010–2027